Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Autolus Therapeutics plc (AUTL)Equibles does not estimate personal net worth.
Get an email with a short summary when Autolus Therapeutics plc publishes a filing, an earnings call transcript or a press release.
Get AUTL alertsAmanda Cray is recorded as Head of Investor Relations at Autolus Therapeutics plc (AUTL). Amanda Cray has spoken on 4 earnings calls and 2 other investor events across 1 company, most recently for Autolus Therapeutics plc on May 14, 2026. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Michael W. Bonney (Chairman and Board Member), Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer) and 4 others.
“With me, our Chief Executive Officer, Dr. Christian Aiton, and Chief Financial Officer, Rob Dolsky.”
“Good afternoon or good evening, everyone, and thank you for joining us for today's presentation. With me, our Chief Executive Officer, Dr. Christian Aitin, and Chief Development Officer, Dr. Matthias Will.”
“Good afternoon or good evening, everyone, and thank you for joining us for today's presentation. With me, our Chief Executive Officer, Dr. Christian Aitin, and Chief Development Officer, Dr. Matthias Will.”
“And thank you for joining us on today's call. With me are Chief Executive Officer, Dr. Christian Itin, and Chief Financial Officer, Rob Dolski.”
“With me are Chief Executive Officer, Dr. Christian Itin, and Chief Financial Officer, Rob Dolski.”
Biotechnology · Healthcare
Head of Investor Relations